Close

We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience.

By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

Find out more
For more information, go to www.arthritisresearchuk.org

Glucosamine move over – here comes chondroitin

Issue 25 Synovium (Autumn 2008)

Download this issue (opens in new window)(120.9 KB)

Glucosamine has been a ‘frequent flyer’ in Synovium columns. To date evidence on chrondroitin sulphate (CS) – a related sulphated glycosaminoglycan – has lagged behind. A lengthy review of the biochemical properties of chondroitin sulphate in osteoarthritic articular tissues published in Annals of the Rheumatic Diseases1 may herald a change. The review details many effects of CS of potential benefit in osteoarthritis, including increasing synthesis of proteoglycans, inhibiting proteases, inhibiting changes in subchondral bone and inhibiting inflammatory processes. We await reports from clinical trials.

Synovium archives

Browse previous issues of Synovium (all issues available as downloadable PDFs)
For more information, go to www.arthritisresearchuk.org.
Arthritis Research UK fund research into the cause, treatment and cure of arthritis. You can support Arthritis Research UK by volunteering, donating or visiting our shops.